Where could CELC trade next? Consensus target price: $160.
Get informed when a big investor buys or sells
+ Follow$72.1
4 analysts in the last 4 months
High: $178 | Low: $140
No recommendations in the last 4 months.
Celcuity (CELC) currently reports a target price of $160. Use the charts on this page to explore Celcuity's target price history and peer comparisons.
Analysts' average 12-month price target for Celcuity is $160, about 124.7% upside from the current share price of $72.1. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $160, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Celcuity, and consider following CELC for alerts when major investors trade the stock.
Celcuity is classified in the Healthcare sector. On target price, it currently shows $160. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CELC with unrelated industries.